Baseline clinical characteristics of the 50 chronic hepatitis C patients treated with PEG-IFN, RBV and protease inhibitor.
- Sayuki Iijima (513617)
- Kentaro Matsuura (156545)
- Tsunamasa Watanabe (426382)
- Koji Onomoto (107253)
- Takashi Fujita (89133)
- Kyoko Ito (694653)
- Etsuko Iio (693145)
- Tomokatsu Miyaki (694654)
- Kei Fujiwara (104718)
- Noboru Shinkai (513618)
- Atsunori Kusakabe (694655)
- Mio Endo (694656)
- Shunsuke Nojiri (694657)
- Takashi Joh (71221)
- Yasuhito Tanaka (39138)
Publication date
February 2015
DOIAbstract
<p>Abbreviations: ALT, alanine aminotransferase; γ-GTP, γ-glutamyl transpeptidase; N.D., not determined; IFN, interferon; RBV, ribavirin; PEG-IFN, pegylated interferon; TVR, transient virological response; NVR, non-virological response.</p><p>rs8099917: TT is favorable for treatment efficacy.</p><p>Data are expressed as numbers for categorical data or the median (range) for continuous data.</p><p>Baseline clinical characteristics of the 50 chronic hepatitis C patients treated with PEG-IFN, RBV and protease inhibitor.</p
Add to ORKG